Literature DB >> 28910798

Expanded Hemodialysis Therapy: Prescription and Delivery.

Nils Heyne1.   

Abstract

Expanded hemodialysis (HDx) therapy is a novel treatment concept in hemodialysis patients, using innovative membrane technology with a high retention onset for improved solute clearance in the upper middle molecular range. HDx therapy thereby resolves a key limitation of current hemodialysis techniques and targets an important pathophysiologic link to many of the sequelae of end-stage renal disease. The present chapter reviews the current evidence and discusses considerations for prescription and delivery of HDx therapy upon implementation in clinical practice.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28910798     DOI: 10.1159/000479263

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  3 in total

1.  Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration.

Authors:  Alba Santos; Nicolás Macías; Almudena Vega; Soraya Abad; Tania Linares; Inés Aragoncillo; Leonidas Cruzado; Cristina Pascual; Marian Goicoechea; Juan Manuel López-Gómez
Journal:  Clin Kidney J       Date:  2020-06-22

2.  Impact of Expanded Hemodialysis Using Medium Cut-off Dialyzer on Quality of Life: Application of Dynamic Patient-Reported Outcome Measurement Tool.

Authors:  Jarrin D Penny; Patricia Jarosz; Fabio R Salerno; Sandrine Lemoine; Christopher W McIntyre
Journal:  Kidney Med       Date:  2021-07-29

Review 3.  Expanded haemodialysis: from operational mechanism to clinical results.

Authors:  Claudio Ronco; Nicola Marchionna; Alessandra Brendolan; Mauro Neri; Anna Lorenzin; Armando J Martínez Rueda
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.